Massive hemorrhage management-a best evidence topic report

Area of Science:

• Trauma and Emergency Medicine
• Transfusion Medicine
• Coagulation Science

Background:

• Massive hemorrhage is a leading cause of preventable death, with potential survival improvements of 10-20% through better bleeding control.
• Current transfusion interventions for acute traumatic coagulopathy lack standardization across medical centers.

Purpose of the Study:

• To provide a comprehensive, evidence-based approach to massive hemorrhage management.
• To compare different transfusion strategies and diagnostic tools for severe bleeding.

Main Methods:

• Literature search of Medline, PubMed, and Google Scholar (2000-present) using keywords and MeSH terms.
• Analysis of articles on massive hemorrhage, component therapy, fresh whole blood, and fibrinogen.
• Grouping evidence by laboratory testing, transfusion interventions, and component therapy outcomes.

Main Results:

• Viscoelastic assays outperform standard tests in identifying coagulopathy and guiding therapy for severe bleeding.
• A 1:1:1:1 ratio of plasma, red blood cells, platelets, and fibrinogen is the optimal replacement for lost whole blood.
• Warm fresh whole blood transfusion shows superiority over component therapy in certain clinical scenarios; cryoprecipitate offers no outcome benefit.

Conclusions:

• Viscoelastic assays and targeted component or whole blood transfusion are key to effective massive hemorrhage management.
• Individualized treatment based on viscoelastic findings and blood loss is recommended.